PT  - JOURNAL ARTICLE
AU  - Kaplan, Edward H.
AU  - Zulli, Alessandro
AU  - Sanchez, Marcela
AU  - Peccia, Jordan
TI  - Scaling SARS-CoV-2 Wastewater Concentrations to Population Estimates of Infection
AID  - 10.1101/2021.07.15.21260583
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.15.21260583
4099  - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260583.short
4100  - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260583.full
AB  - Monitoring the progression of SARS‐CoV‐2 outbreaks requires accurate estimates of infection rates. Estimation methods based on observed cases are biased due to changes in testing over time. Here we report an approach based upon scaling daily concentrations of SARS‐CoV‐2 RNA in wastewater to infections that produces representative estimates due to the consistent population contribution of fecal material to the sewage collection system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKaplan: support from Yale School of Management faculty research fund Zulli, Sanchez, Peccia: pilot grant from the Yale University COVID-19 Research Resource FundAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No human subjects involved and hence no IRB; only SARS-CoV-2 RNA concentrations measured in sludge from wastewater treatment plant and COVID-19 tests/case counts used in study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in study included as supplemental information.